Armata Pharmaceuticals, Inc. (AMEX: ARMP) is a Healthcare company (Biotechnology) with a market capitalization of $99M. The Maz Rating grades it against the other companies in its sector.
Armata Pharmaceuticals, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $2.66, Armata Pharmaceuticals, Inc. trades at 14.4x sales. Over the last twelve months it generated about $7M of revenue and a net loss of $135M. It runs a gross margin of 75.0%, an operating margin of -622.9% and a net margin of -1710.1%. It shows return on equity of 58.1%, return on invested capital of -50.0% and a free cash flow yield of -27.0%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 0.12. Over the past 52 weeks the share price ranged from $2.40 to $14.98, with a beta of 1.41.
Armata Pharmaceuticals, Inc. does not currently pay a dividend.
4 Wall Street analyst ratings cover the stock: 4 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.